Stay updated on FF-10101-01 Study in Relapsed AML Clinical Trial

Sign up to get notified when there's something new on the FF-10101-01 Study in Relapsed AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FF-10101-01 Study in Relapsed AML Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.6%
    Check dated 2025-05-01T23:24:39.000Z thumbnail image
  2. Check
    15 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2025-04-24T15:24:53.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed information about a Phase 1 study of FF-10101-01 for acute myeloid leukemia, and the addition of a new revision number and masking description.
    Difference
    24%
    Check dated 2025-04-17T10:53:53.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to December 24, 2024.
    Difference
    0.8%
    Check dated 2025-04-10T05:33:38.000Z thumbnail image
  5. Check
    36 days ago
    No Change Detected
  6. Check
    58 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-12T05:28:50.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-25T19:14:19.000Z thumbnail image

Stay in the know with updates to FF-10101-01 Study in Relapsed AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FF-10101-01 Study in Relapsed AML Clinical Trial page.